$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Transdermal administration of oxybutynin 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/02
출원번호 US-0193661 (1994-02-08)
발명자 / 주소
  • Lee Eun S. (Redwood City CA) Nedberge Diane E. (Los Altos CA) Yum Su I. (Los Altos CA)
출원인 / 주소
  • ALZA Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 51  인용 특허 : 0

초록

The present invention is directed to the transdermal administration of oxybutynin together with a suitable permeation enhancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in oxybutynin- and permeation enhancer-transmitting relation with the ski

대표청구항

A device for the transdermal administration, at a therapeutically effective rate, of oxybutynin, which device comprises: (a) a reservoir consisting essentially of a therapeutically effective amount of an oxybutynin base, a skin permeation-enhancing amount of a monoglyceride or a mixture of monoglyce

이 특허를 인용한 특허 (51)

  1. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  2. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  3. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  4. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  5. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  6. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  7. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  8. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  9. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  10. Bozik, Michael E; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  11. Bozik, Michael E.; Hebrank, Gregory; Farwell, Wildon; Petzinger, Jr., Thomas; Dworetzky, Steven, Compositions and methods for treating conditions related to increased eosinophils.
  12. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  13. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  14. Bozik, Michael E.; Gribkoff, Valentin; Petzinger, Jr., Thomas, Compositions and methods of using (R)-pramipexole.
  15. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions and methods of using (R)-pramipexole.
  16. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  17. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  18. Anu Mahashabde ; Martha Francine Kay ; Donald F. Koelmel, Device and method for treating urinary incontinence in females.
  19. Nakamura Katsuhiro,JPX ; Koga Nobuyuki,JPX, Formulation for percutaneous administration for treating disturbance in micturition.
  20. Landrau Felix A. ; Nedberge Diane E. ; Hearney Linda Mary, Incorporating poly-N-vinyl amide in a transdermal system.
  21. Matsuura David G. ; Gillespie Walter Dean ; Greelis John Patrick ; Parsons Charles Lowell ; Sirivong Mikxay ; Zupkas Paul F., Intravesical infuser.
  22. Hyatt Gary F. ; Bostic William M., Medical applicator and method.
  23. Matsuura David G. ; Gillespie Walter Dean ; Greelis John Patrick ; Parsons Charles Lowell ; Sirivong Mikxay ; Zupkas Paul F., Method for delivering a medication.
  24. Zinger, Menni Menashe, Methods for the treatment of hyperhidrosis.
  25. Robert Martin Gale, Methods for transdermal drug administration.
  26. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same.
  27. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutnin.
  28. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutynin.
  29. Jansen, Rolf R.; Coronado, Dina J., Multilayer drug delivery system with barrier against reservoir material flow.
  30. Kimball, Michael W., Peelable pouch for transdermal patch and method for packaging.
  31. Kimball, Michael W., Peelable pouch for transdermal patch and method for packaging.
  32. Kimball, Michael W., Peelable pouch for transdermal patch and method for packaging.
  33. Lee Eun Soo ; Yum Su II, Permeation enhances for transdermal drug delivery compositions, devices and methods.
  34. Kurita,Hisakazu; Tateishi,Tetsuro; Suzuki,Tatsuaki; Higo,Naruhito, Preparations for percutaneous absorption.
  35. Beste Russell D. ; Hamlin Richard D., Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate.
  36. Chen, Weirong; Humora, Michael; Kwok, Daw-Iong Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  37. Chen, Weirong; Humora, Michael; Kwok, Daw-long Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  38. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  39. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  40. Yum, Su Il; Theeuwes, Felix, Transdermal delivery system for sufentanil.
  41. Yum, Su Il; Theeuwes, Felix, Transdermal delivery system for sufentanil.
  42. Yum, Su Il; Theeuwes, Felix, Transdermal delivery systems.
  43. Watanabe, Tyler; Gale, Robert M., Transdermal drug delivery device package with improved drug stability.
  44. Deshmukh, Abhijit Mukund; Dixit, Akhilesh; Kumar, Prasanna; Bindra, Vikram, Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders.
  45. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  46. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  47. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  48. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  49. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  50. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
  51. Bond, Richard A.; Glass, Mitchell, Use of beta-adrenergic inverse agonists for smoking cessation.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로